Editorial: ApoAII controversy still in rabbit?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 12, 2009, Pages 1984-1985

  Shimano, Hitoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; DIMER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOMER; PHOSPHOLIPID; TRIACYLGLYCEROL; UPSTREAM STIMULATORY FACTOR 1; HIGH DENSITY LIPOPROTEIN; RECOMBINANT PROTEIN;

ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; CATABOLISM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; DYSLIPIDEMIA; EDITORIAL; ENZYME ACTIVITY; GENE CLUSTER; GENE EXPRESSION; GENETIC ASSOCIATION; HYPERLIPIDEMIA; KNOCKOUT MOUSE; LIPOPROTEIN METABOLISM; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABBIT; SPECIES DIFFERENCE; TRANSGENIC MOUSE; ANIMAL; ATHEROGENIC DIET; BLOOD; DISEASE MODEL; GENETICS; HUMAN; NOTE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOLIPOPROTEIN A-II; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; HUMANS; LIPOPROTEINS, HDL; RABBITS; RECOMBINANT PROTEINS;

EID: 73849148324     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.196683     Document Type: Editorial

References (6)

1. Blanco-Vaca F, Escola-Gil JC, Martin-Campos JM, Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res. 2001;42:1727-1739.
2. Kalopissis AD, Pastier D, Chambaz J. Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance. Curr Opin Lipidol. 2003;14:165-172.
3. Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN. The role of triglyc-eride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscler Thromb Vasc Biol. 1997;17:715-722.
4. Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM. Apoli-poprotein A-II is inversely associated with risk of future coronary artery disease. Circulation. 2007;116:2029-2035.
5. Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, Duan XJ, Soro-Paavonen A, Naukkarinen J, Saarela J, Laakso M, Ehnholm C, Taskinen MR, Peltonen L. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36: 371-376.
6. Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem. 1999;274:1216-1225.